제1회
Point-of-Care Testing
-Point of Care 검사 심포지엄-
분자진단의 실용화
2월 19일∼20일

개발기간의 단축과 경비절감에 따라 임상시험을 효율화할 필요성이 커지는 가운데 환자를 계층화하기 위해 Point of Care 검사를 이용하는 케이스가 증가하고 있습니다. 이 심포지엄에서는 Point of Care 진단의 기술 및 동향을 다루며 신약 개발 분야의 각종 용도에 대한 적합성을 검토하고, 진단 서비스 프로바이더 및 제약회사 양측에 대한 비지니스 기회를 명확히 합니다. 또한 동반진단의 도입 관련 문제 및 Point of Care 검사가 유효한 툴인 이유 등도 제시될 예정입니다.

Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Diagnostics, Pathology, Infectious Diseases, R&D, Product Development, and Biotechnology.

Topics will include, but are not limited to:

• Technologies and trends in point-of-care diagnostics
• Deciding which companion diagnostic test to use
• Implementing companion diagnostics
• Partnering with a point-of-care diagnostic developer
• Deciding on criteria for selecting a POC device or provider
• Economics of the POC model for pharma
• Infrastructure needed to make POC work in pharma
• When in the drug development cycle is the right time to bring in a companion diagnostic?
• Who should own the test?
• Who should develop it?
• Can central labs obviate the need for POC in clinical trials?
• Which POC tests are ready for market?

The deadline for submission is July 29, 2011.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.